Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.12
Delayed Data
As of Mar 24
 +0.01 / +0.47%
Today’s Change
1.81
Today|||52-Week Range
3.35
+2.42%
Year-to-Date
No recent news for Geron Corp.

Today’s Trading

Previous close2.11
Today’s open2.11
Day’s range2.09 - 2.15
Volume938,340
Average volume (3 months)1,349,839
Market cap$337.4M
Dividend yield--
Data as of 3:59pm ET, 03/24/2017

Growth & Valuation

Earnings growth (last year)-63,433.33%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)-83.06%
P/E ratioNM
Price/Sales53.43
Price/Book2.76

Competitors

 Today’s
change
Today’s
% change
AGENAgenus Inc-0.04-1.02%
NVAXNovavax Inc-0.01-0.79%
PDLIPDL BioPharma Inc-0.05-2.46%
BLCMBellicum Pharmaceuti...-0.86-6.67%
Data as of 3:59pm ET, 03/24/2017

Financials

Next reporting dateMay 4, 2017
EPS forecast (this quarter)-$0.05
Annual revenue (last year)$6.2M
Annual profit (last year)-$29.5M
Net profit margin-479.34%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs